NCT04982588 - Evolut PRO China Clinical Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2021

Primary Completion Date

March 17, 2023

Study Completion Date

May 15, 2028

Conditions

Severe, Symptomatic Aortic Stenosis

Interventions

DEVICE

Medtronic CoreValve™ Evolut™ PRO System

"The system comprised of the following three components:~1. CoreValve™ Evolut™ PRO Transcatheter Aortic Valve (TAV)~2. EnVeo™ PRO Delivery Catheter System (DCS)~3. EnVeo™ PRO Loading System (LS)"

Trial Locations (4)

100000

Beijing Anzhen Hospital, Capital Medical University, Beijing

Chinese PLA General Hospital, Chinese PLA Medical School, Beijing

310009

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

610000

West China Hospital of Sichuan University, Chengdu